This page is intended for Canadian audiences only.
PoNS is a medical device commercially available only in Canada.
It is not available for sale in the United States.
By clicking “Accept” you acknowledge your understanding of this message and that you are a resident of Canada.
Cette page est destinée aux résidents canadiens uniquement.
PoNS est un appareil médical offert sur le marché canadien seulement; il n’est pas vendu aux États-Unis.
En cliquant « Accepter », vous reconnaissez comprendre ce message et être résident du Canada.
Click here if you are not a Canadian resident.
Cliquez ici si vous n'êtes pas résident canadien.
The PoNS™ device
What is it?
How has it helped?
Various locations
If you or your loved one continue to experience these issues, contact your nearest clinic for a free phone consultation to learn more about PoNS Treatment™.
PoNS™ (short for Portable Neuromodulation Stimulator) is an innovative, non-surgical medical device that gently stimulates the surface of the tongue, exciting the neural network flowing to the brain. This neural activity is believed to enable neuroplasticity, which may restore lost function.
PoNS Treatment™ is a 14-week program that combines in-clinic and in-home use of the PoNS™ device guided by a Certified PoNS™ Trainer.
“My walking improved by ways of not looking impaired which made me feel more confident and helped me engage in social activities that I would have passed on before the PoNS Treatment™.” - RG 48-year-old male, mmTBI Patient
Find local support groups who can help you through your journey.
The PoNS™ device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS). Electrical stimulation SHOULD NOT be used: if there is an active or suspected malignant tumor, in areas of recent bleeding or open wounds, or in areas that lack normal sensation. PoNS™ has not been tested on, and thus should not be used by, individuals under the age of 18 or who are pregnant. PoNS™ should not be used in patients sensitive to nickel, gold, or copper.
PoNS and PoNS Treatment are trademarks of Helius Medical, Inc
Regulatory Disclaimer
Privacy Policy
PoNS™ is an authorized medical device and commercially available in Canada. PoNS™ is an investigational device in the US, EU, and Australia and is currently under review for market clearance by the AUS TGA; PoNS™ is not commercially available in the US, EU, or Australia.
The device is intended for use as a short term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with physical therapy. The device is intended for use as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy.
